Difference between revisions of "Main Page"
Jump to navigation
Jump to search
| Line 32: | Line 32: | ||
*[[Media:Why_QIBA_PET-CT_specifics.pdf|"Why QIBA?" - Specifics associated with PET-CT device and software manufacturers.]] | *[[Media:Why_QIBA_PET-CT_specifics.pdf|"Why QIBA?" - Specifics associated with PET-CT device and software manufacturers.]] | ||
*[[Media:Why_QIBA_MR_specifics.pdf|"Why QIBA?" - Specifics associated with MR device and software manufacturers.]] | *[[Media:Why_QIBA_MR_specifics.pdf|"Why QIBA?" - Specifics associated with MR device and software manufacturers.]] | ||
| − | *[[Media: | + | *[[Media:HHSN268201000050C_QIBA_Proposed_Workplan_11-22-2010.doc|QIBA Work Plan (2010.11.22)]] |
| − | |||
*[[Media:EU.2009.08.04 Guideline on Clinical evaluation of diagnostic agents.pdf|EMEA Guideline on Clinical Evaluation of Diagnostic Agents (2009.08.04)]] | *[[Media:EU.2009.08.04 Guideline on Clinical evaluation of diagnostic agents.pdf|EMEA Guideline on Clinical Evaluation of Diagnostic Agents (2009.08.04)]] | ||
*[[Media:EU.2009.08.04 Appendix 1 to the guideline.pdf|EMEA Guideline - Appendix 1 (2009.08.04)]] | *[[Media:EU.2009.08.04 Appendix 1 to the guideline.pdf|EMEA Guideline - Appendix 1 (2009.08.04)]] | ||
Revision as of 15:34, 9 January 2011
This Wiki is for collaborative creation of QIBA materials and ongoing activities.
Quantitative Imaging Biomarkers Alliance (QIBA)
QIBA Mission: Improve the value and practicality of quantitative biomarkers by reducing variability across devices, patients and time.
QIBA is an initiative to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice by engaging researchers, healthcare professionals and industry . This involves:
- collaborating to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time.
- accelerating the development and adoption of hardware and software standards needed to achieve accurate and reproducible quantitative results from imaging methods.
QIBA develops Profile specifications and coordinates the necessary research and qualification groundwork.
QIBA Committees
QIBA currently has four active committees:
Working Documents
- "Why QIBA?" - Specifics associated with CT device and software manufacturers.
- "Why QIBA?" - Specifics associated with PET-CT device and software manufacturers.
- "Why QIBA?" - Specifics associated with MR device and software manufacturers.
- QIBA Work Plan (2010.11.22)
- EMEA Guideline on Clinical Evaluation of Diagnostic Agents (2009.08.04)
- EMEA Guideline - Appendix 1 (2009.08.04)
- Oncology section from 2009 Imaging Biomarkers Roundtable
- QIBA posters from RSNA 2008 Annual Meeting
- QIBA and UPICT posters from RSNA 2009 Annual Meeting
- QIBA and UPICT posters from RSNA 2010 Annual Meeting
Ad Hoc Committees
NEW: "How To" help pages
<This Wiki is a Work In Progress: read Help, create an account, contribute>